Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Diagnosis and Differential Diagnosis of Cushing’s Syndrome.

Oelkers W.

N Engl J Med. 2017 Jul 13;377(2):e3. doi: 10.1056/NEJMc1705984. No abstract available.

PMID:
28704026
2.

Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

Quinkler M, Oelkers W, Remde H, Allolio B.

Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):17-24. doi: 10.1016/j.beem.2014.08.008. Epub 2014 Aug 27. Review.

PMID:
25617169
3.

Quality of life rated too negatively.

Oelkers W.

Dtsch Arztebl Int. 2014 Mar 28;111(13):224. doi: 10.3238/arztebl.2014.0224a. No abstract available.

4.

Deficits in the management of patients with adrenocortical carcinoma in Germany.

Johanssen S, Hahner S, Saeger W, Quinkler M, Beuschlein F, Dralle H, Haaf M, Kroiss M, Jurowich C, Langer P, Oelkers W, Spahn M, Willenberg HS, Mäder U, Allolio B, Fassnacht M.

Dtsch Arztebl Int. 2010 Dec;107(50):885-91. doi: 10.3238/arztebl.2010.0885. Epub 2010 Dec 17.

5.

In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.

Diederich S, Quinkler M, Mai K, Schöneshöfer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E.

Horm Metab Res. 2011 Jan;43(1):66-71. doi: 10.1055/s-0030-1267170. Epub 2010 Oct 5.

PMID:
20925019
7.

Is there a need for vitamin C supplementation of the normal diet? Effects of in vivo ascorbate depletion on adrenal function.

Bähr V, Pfeiffer AF, Oelkers W.

Am J Clin Nutr. 2008 Jan;87(1):191; author reply 191-2. doi: 10.1093/ajcn/87.1.191. No abstract available.

PMID:
18175756
8.

Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man.

Bähr V, Franzen N, Oelkers W, Pfeiffer AF, Diederich S.

Eur J Endocrinol. 2006 Dec;155(6):845-8.

PMID:
17132754
9.

Vasopressin excess and hyponatremia: hydrocortisone treatment should be considered.

Bähr V, Franzen NF, Pfeiffer AF, Diederich S, Oelkers W.

Am J Kidney Dis. 2006 Aug;48(2):339; author reply 339-40. No abstract available.

PMID:
16860205
10.

Metabolism of synthetic steroids by the human placenta.

Bähr V, Oelkers W, Pfeiffer AF, Diederich S.

Placenta. 2007 May-Jun;28(5-6):588-9. Epub 2006 Jul 3. No abstract available.

PMID:
16820201
11.
12.

Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties.

Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, Bahr V.

Eur J Endocrinol. 2004 Sep;151(3):397-406.

PMID:
15362971
13.

Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.

Diederich S, Scholz T, Eigendorff E, Bumke-Vogt Ch, Quinkler M, Exner P, Pfeiffer AF, Oelkers W, Bähr V.

Horm Metab Res. 2004 Jun;36(6):423-9.

PMID:
15241735
14.

The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation.

Quinkler M, Diederich S, Bähr V, Oelkers W.

Horm Metab Res. 2004 Jun;36(6):381-6. Review.

PMID:
15241728
15.

Mineralocorticoid substitution in pregnant Addisonian women.

Oelkers W.

J Endocrinol Invest. 2004 Apr;27(4):406. No abstract available.

PMID:
15233565
16.

Drospirenone, a progestogen with antimineralocorticoid properties: a short review.

Oelkers W.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):255-61. Review.

PMID:
15134826
17.

Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients.

Spies CD, von Dossow V, Eggers V, Jetschmann G, El-Hilali R, Egert J, Fischer M, Schröder T, Höflich C, Sinha P, Paschen C, Mirsalim P, Brunsch R, Hopf J, Marks C, Wernecke KD, Pragst F, Ehrenreich H, Müller C, Tonnesen H, Oelkers W, Rohde W, Stein C, Kox WJ.

Anesthesiology. 2004 May;100(5):1088-100.

PMID:
15114205
18.

Introduction. Hormone replacement therapy and the cardiovascular system: targeting the RAAS.

Oelkers W.

Climacteric. 2003 Oct;6 Suppl 3:11-2. No abstract available.

PMID:
15018243
19.
20.

The human kidney is a progesterone-metabolizing and androgen-producing organ.

Quinkler M, Bumke-Vogt C, Meyer B, Bähr V, Oelkers W, Diederich S.

J Clin Endocrinol Metab. 2003 Jun;88(6):2803-9.

PMID:
12788891
21.

Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases.

Diederich S, Franzen NF, Bähr V, Oelkers W.

Eur J Endocrinol. 2003 Jun;148(6):609-17.

PMID:
12773132
22.

[Monogenic hypertension].

Bähr V, Oelkers W, Diederich S.

Med Klin (Munich). 2003 Apr 15;98(4):208-17. Review. German.

PMID:
12715144
23.

Clinical diagnosis of hyper- and hypocortisolism.

Oelkers W.

Noise Health. 2000;2(7):39-48.

24.

Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.

Oelkers W.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:19-26; discussion 42-3. Review.

PMID:
12659403
25.

Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.

Quinkler M, Troeger H, Eigendorff E, Maser-Gluth C, Stiglic A, Oelkers W, Bähr V, Diederich S.

J Endocrinol. 2003 Feb;176(2):185-92.

PMID:
12553867
26.

11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.

Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V.

J Clin Endocrinol Metab. 2002 Dec;87(12):5695-701.

PMID:
12466373
27.

Expression of the progesterone receptor and progesterone- metabolising enzymes in the female and male human kidney.

Bumke-Vogt C, Bähr V, Diederich S, Herrmann SM, Anagnostopoulos I, Oelkers W, Quinkler M.

J Endocrinol. 2002 Nov;175(2):349-64.

PMID:
12429033
28.

Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.

Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bahr V.

Eur J Endocrinol. 2002 Jun;146(6):789-99.

PMID:
12039699
29.

The renin-aldosterone system and drospirenone.

Oelkers W.

Gynecol Endocrinol. 2002 Feb;16(1):83-7. Review. No abstract available.

PMID:
11915587
30.

Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed.

Oelkers W, Tuchelt H.

Clin Endocrinol (Oxf). 2001 Dec;55(6):821-2. No abstract available.

PMID:
11895228
31.

Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults.

Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bähr V, Oelkers W.

Clin Endocrinol (Oxf). 2001 May;54(5):665-71. Erratum in: Clin Endocrinol (Oxf) 2001 Oct;55(4):563.

PMID:
11380498
32.

Therapeutic strategies in adrenal insufficiency.

Oelkers W, Diederich S, Bähr V.

Ann Endocrinol (Paris). 2001 Apr;62(2):212-6. Review.

PMID:
11353897
33.

11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine.

Diederich S, Quinkler M, Burkhardt P, Grossmann C, Bähr V, Oelkers W.

Eur J Clin Invest. 2000 Dec;30 Suppl 3:21-7. Review.

PMID:
11281363
34.

Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.

Oelkers W.

Eur J Contracept Reprod Health Care. 2000 Dec;5 Suppl 3:17-24. Review.

PMID:
11246598
35.

Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues.

Quinkler M, Oelkers W, Diederich S.

Eur J Endocrinol. 2001 Feb;144(2):87-97. Review.

PMID:
11182744
36.

Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney.

Quinkler M, Johanssen S, Bumke-Vogt C, Oelkers W, Bähr V, Diederich S.

Mol Cell Endocrinol. 2001 Jan 22;171(1-2):21-4.

PMID:
11165007
37.

In vivo measurement of renal 11beta-hydroxysteroid dehydrogenase type 2 activity.

Quinkler M, Oelkers W, Diederich S.

J Clin Endocrinol Metab. 2000 Dec;85(12):4921-3. No abstract available.

PMID:
11134165
38.

Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy.

Stratakis CA, Papageorgiou T, Premkumar A, Pack S, Kirschner LS, Taymans SE, Zhuang Z, Oelkers WH, Carney JA.

J Clin Endocrinol Metab. 2000 Nov;85(11):4359-66.

PMID:
11095480
39.

Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact.

Jordan J, Toka HR, Heusser K, Toka O, Shannon JR, Tank J, Diedrich A, Stabroth C, Stoffels M, Naraghi R, Oelkers W, Schuster H, Schobel HP, Haller H, Luft FC.

Circulation. 2000 Nov 21;102(21):2611-8.

PMID:
11085965
40.

Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.

Oelkers W, Diederich S, Bähr V.

J Clin Endocrinol Metab. 2000 Sep;85(9):3266-70.

PMID:
10999820
41.

Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.

Tuchelt H, Dekker K, Bähr V, Oelkers W.

Clin Endocrinol (Oxf). 2000 Sep;53(3):301-7. Erratum in: Clin Endocrinol (Oxf) 2001 Jan;54(1):135.

PMID:
10971446
42.

Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.

Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R.

Gynecol Endocrinol. 2000 Jun;14(3):204-13.

PMID:
10923282
43.

In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I.

Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bähr V, Oelkers W.

Eur J Endocrinol. 2000 Feb;142(2):200-7.

PMID:
10664531
44.

Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites.

Quinkler M, Johanssen S, Grossmann C, Bähr V, Müller M, Oelkers W, Diederich S.

J Clin Endocrinol Metab. 1999 Nov;84(11):4165-71.

PMID:
10566667
45.

Dehydroepiandrosterone for adrenal insufficiency.

Oelkers W.

N Engl J Med. 1999 Sep 30;341(14):1073-4. No abstract available.

PMID:
10502598
47.

[11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids].

Diederich S, Quinkler M, Hanke B, Bähr V, Oelkers W.

Dtsch Med Wochenschr. 1999 Jan 22;124(3):51-5. Review. German. No abstract available.

PMID:
9987486
48.

The role of high- and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency.

Oelkers W.

Eur J Endocrinol. 1998 Dec;139(6):567-70. Review. No abstract available.

PMID:
9916857
49.

[Addison disease, diagnosis and therapy].

Oelkers W.

Med Klin (Munich). 1998 Nov 15;93(11):683. German. No abstract available.

PMID:
9872046
50.

Torsemide inhibits aldosterone secretion in vitro.

Goodfriend TL, Ball DL, Oelkers W, Bähr V.

Life Sci. 1998;63(3):PL45-50.

PMID:
9698054

Supplemental Content

Loading ...
Support Center